Education
About Us
Working with TipRanks
Follow Us
XBiotech (XBIT)
NASDAQ:XBIT
Total Valuation
XBiotech has a market cap or net worth of $65.85M. The enterprise value is ―.
Market Cap$65.85M
Enterprise Value―
Share Statistics
XBiotech has 30,487,732 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding30,487,732
Owned by Insiders12.54%
Owned by Institutions1.04%
Financial Efficiency
XBiotech’s return on equity (ROE) is -0.21 and return on invested capital (ROIC) is -21.85%.
Return on Equity (ROE)-0.21
Return on Assets (ROA)-0.19
Return on Invested Capital (ROIC)-21.85%
Return on Capital Employed (ROCE)-0.23
Revenue Per Employee0.00
Profits Per Employee-418.82K
Employee Count92
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of XBiotech is ―. XBiotech’s PEG ratio is -0.06.
PE Ratio―
PS Ratio0.00
PB Ratio0.66
Price to Fair Value0.66
Price to FCF-3.73
Price to Operating Cash Flow-3.20
PEG Ratio-0.06
Income Statement
In the last 12 months, XBiotech had revenue of 0.00 and earned -38.53M in profits. Earnings per share was -1.26.
Revenue0.00
Gross Profit0.00
Operating Income-42.47M
Pretax Income-38.56M
Net Income-38.53M
EBITDA-36.01M
Earnings Per Share (EPS)-1.26
Cash Flow
In the last 12 months, operating cash flow was -23.51M and capital expenditures -339.00K, giving a free cash flow of -23.85M billion.
Operating Cash Flow-23.51M
Free Cash Flow-23.85M
Free Cash Flow per Share-0.78
Dividends & Yields
XBiotech pays an annual dividend of $2.47, resulting in a dividend yield of ―
Dividend Per Share$2.47
Dividend Yield―
Payout Ratio―
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.33
52-Week Price Change-65.32%
50-Day Moving Average2.46
200-Day Moving Average2.85
Relative Strength Index (RSI)48.17
Average Volume (3m)63.63K
Important Dates
XBiotech upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend DateJul 15, 2021
Financial Position
XBiotech as a current ratio of 11.56, with Debt / Equity ratio of 0.00%
Current Ratio11.56
Quick Ratio11.56
Debt to Market Cap0.09
Net Debt to EBITDA4.32
Interest Coverage Ratio-52.63
Taxes
In the past 12 months, XBiotech has paid -32.00K in taxes.
Income Tax-32.00K
Effective Tax Rate<0.01
Enterprise Valuation
XBiotech EV to EBITDA ratio is 1.12, with an EV/FCF ratio of 1.30.
EV to Sales0.00
EV to EBITDA1.12
EV to Free Cash Flow1.30
EV to Operating Cash Flow1.36
Balance Sheet
XBiotech has $147.37M in cash and marketable securities with $0.00 in debt, giving a net cash position of $147.37M billion.
Cash & Marketable Securities$147.37M
Total Debt$0.00
Net Cash$147.37M
Net Cash Per Share$4.83
Tangible Book Value Per Share$5.98
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for XBiotech is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―